Cardiacx

Company Overview

Snapshot

Founded in January 2007, Cardiacx operated with 1–10 employees, developing miniature cardiac resuscitation systems. The company ceased operations in May 2019.

Business overview

Cardiacx develops, manufactures, and markets miniature cardiac resuscitation systems, including personal defibrillators. The company's core technology centers on its Personal External Defibrillator (PED) series, which are user-friendly, portable defibrillators designed to shorten response times for sudden cardiac arrest. Cardiacx serves markets focused on emergency response, home care, and patients at risk for sudden cardiac arrest, operating within the Health Tech & Life Sciences sector, specifically targeting medical devices and medical treatment & therapeutics.

Company Intelligence Q&A

What is Cardiacx's primary focus?

Cardiacx develops, manufactures, and markets miniature cardiac resuscitation systems, including personal defibrillators, designed to provide rapid intervention during sudden cardiac arrest.

What products does Cardiacx offer?

Cardiacx offers a range of Personal External Defibrillators (PED), including the PED-S for children, the PED-M for adults, and the PED-L for large or obese patients, each designed with varying energy delivery capabilities.

When was Cardiacx founded?

Cardiacx was founded in January 2007.

What is the operational status of Cardiacx?

Cardiacx ceased to operate in May 2019.

What is the key innovation behind Cardiacx's products?

Cardiacx's key innovation is its smartphone-sized Personal External Defibrillator (PED), which aims to shorten the response time for sudden cardiac arrest to under five minutes through its user-friendly, portable design.